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Background: Access to essential medicines is core to saving lives and improving health outcomes of people
worldwide, particularly in the low- and middle-income countries. Having a trained pharmacy workforce to manage
the supply chain and safely dispense medicines is critical to ensuring timely access to quality pharmaceuticals and
improving child health outcomes.
Methods/Design: This study measures the impact of an innovative pharmacy assistant training program in the
low-income country of Malawi on access to medicines and health outcomes. We employ a cluster quasi-experimental
design with pre-and post-samples and decision analytic modeling to examine access to and the use of medicines for
malaria, pneumonia, and diarrhea for children less than 5 years of age. Two intervention districts, with newly trained
and deployed pharmacy assistants, and two usual care comparison districts, matched on socio-economic, geographic,
and health-care utilization indicators, were selected for the study. A baseline household survey was conducted in March
2014, prior to the deployment of pharmacy assistants to the intervention district health centers. Follow-up surveys are
planned at 12- and 24-months post-deployment. In addition, interviews are planned with caregivers, and time-motion
studies will be conducted with health-care providers at the health centers to estimate costs and resources use.
Discussion: This impact evaluation is designed to provide data on the effects of a novel pharmacy assistant program
on pharmaceutical systems performance, and morbidity and mortality for the most common causes of death for
children under five. The results of this study should contribute to policy decisions about whether and how to scale up
the health systems strengthening workforce development program to have the greatest impact on the supply chain
and health outcomes in Malawi.
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Prompt access to essential medicines can improve health
outcomes, including saving lives in low- and middle-
income countries (LMICs) [1,2]. However, access to most
health-related commodities in LMICs remains low. For
example, the mean public sector availability of essential
medicines in the World Health Organization (WHO)
African region is reported to be only 29.4% [3]. The
lack of access to essential medicines has an especially
large impact on children in Africa, potentially contrib-
uting to morbidity and mortality, from otherwise treatable
diseases including malaria, pneumonia, and diarrhea [4].
In Malawi, UNICEF estimated that of 39,495 child deaths,
19% were due to malaria, 16% due to pneumonia, and
10% due to diarrheal diseases, a total of 45% [5].
Reasons for persistently low access to medicines in-
clude (1) inadequate financing; (2) regulatory problems;
(3) lengthy procurement processes; (4) lack of incentives
for maintaining sufficient stock levels; (5) poor logistics
management (e.g., forecasting, distribution, information
technology (IT) systems); (6) corruption; and (7) lack of
qualified health workers to manage the medicines supply
chain [2,6-8]. An effective medicines supply chain with
sufficient numbers of well-trained and motivated human
resources is an essential component of a robust health
system [9,10]. However, according to the 2011 Malawi
Health Sector Strategic Plan (HSSP) [11], there were
only five pharmacists in the country’s public health sys-
tem and only 24% of the established positions for phar-
macy technicians were filled.
Task shifting has been proposed as a potential solution
to increase the number of health workers in Malawi [12].
In their review of task-shifting studies, Mdege et al. [13]
found that this may be an effective and cost-effective ap-
proach to expanding access to antiretroviral therapy where
the health workforce is limited. Babigumira et al. [14] have
also shown that task shifting may lead to cost and phys-
ician personnel savings in ART follow-up in Uganda and
could contribute to mitigating health worker crises.
In the absence of qualified personnel, logistics and
supply chain functions in pharmacies at health centers
are performed by clinical health workers such as medical
assistants and nursing aides [15,16]. This has the distinct
disadvantage of diverting these cadres from their core
duty of direct patient care [16]. And because they lack
training in medicines logistics management, inefficien-
cies occur in supply chain management as well as clin-
ical care [16]. Sometimes, pharmacy work is delegated to
untrained hospital attendants or lay community mem-
bers [12,15]; this can lead to adverse consequences for
patients along with systems inefficiencies.
An alternative and potentially more efficient model is
one in which pharmacy services, such as dispensing and
logistics and supply management, at primary healthcenters are provided by a lower-level cadre of pharmacy
worker called a pharmacy assistant (PA) [16,17]. This
cadre of pharmacy worker receives up to 2 years of
training in pharmacy culminating in the award of a
Certificate in Pharmacy. Such a model is not new to
Malawi. Until 1999, pharmacy assistants had been trained
and deployed at district and central hospitals, but this pro-
gram was discontinued as the Ministry of Health focused
on developing a diploma and subsequently a degree pro-
gram in Pharmacy [18,19]. Owing to the continued short-
age of pharmacy workers at the health facility level
[11,18], VillageReach, a Seattle-based international non-
governmental organization with expertise in supply chain
management, initiated an enhanced PA training program,
in conjunction with the Malawi College of Health Sciences
and the Malawi Ministry of Health, which is now being
implemented in Malawi.
A crucial aspect of the program is that, as part of their
training, PAs are deployed at district hospitals in their
first year of training and in primary health centers in
their second year of training for five months of intensive,
supervised, field-based practicums. This has two potential
advantages: 1) students should benefit from a supervised
experiential learning environment that is characteristic of
their future work environment, and 2) it should immedi-
ately alleviate the human resource gap at the primary
health center and potentially, have an immediate effect on
improving access to medicines at the community level.
There is a dearth of robust evidence on the impact of
strengthening human resources capacity for medicines
supply on access to medicines and health outcomes [15].
To bridge this knowledge gap, we designed an evaluation
of the impact of PA training and deployment on access
to essential medicines for malaria, pneumonia, and diar-
rhea (i.e., artemisinin-based combination therapies (ACTs),
antibiotics, and oral rehydration salts (ORS), respectively),
the leading causes of childhood mortality in Malawi [5]. In
performing this evaluation, our hypothesis is that PA train-
ing and deployment will improve medicines management,
logistics information flow for essential medicines, and sup-
ply chain functions at the primary health centers. This
could lead to improved availability of medicines at primary
health centers, increased access to essential medicines in
the community, and improved health outcomes. We also
hypothesize that PA training and deployment will be cost-
effective from both the perspective of the Malawi Ministry
of Health and a societal perspective. The specific objectives
of this evaluation are the following:
1. To assess the impact of the PA training and
deployment on operational efficiency at health
centers;
2. To assess the impact of PA training and deployment
on access to antimalarials, antibiotics, and ORS at
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symptoms of pneumonia, and diarrhea, respectively;
3. To model the impact of PA training and deployment
on mortality and disability-adjusted life-years
(DALYs);




The evaluation includes three complementary compo-
nents: (1) a health center (HC)-based time-motion and
patient survey, (2) a population-based household survey,
and (3) a model-based health and economic analysis.
The HC-based time-motion and patient surveys as well
as the population-based household survey use a quasi-
experimental, separate pre-post samples design (Figure 1)
[20]. The model-based health and economic analysis
uses decision analytic methods.
The primary outcome of the time-motion and patient
survey is operational efficiency, measured as patient wait
time at HCs. The primary outcome of the household
survey is access to ACTs, antibiotics, and ORS. We
adopted the access-to-medicines (coverage rate) defin-
ition used in the Malawi Demographic and Health
Survey (DHS), 2010 [21], i.e., the percentage of children
with non-severe malaria, pneumonia, or diarrhea in the
last 2 weeks who obtained a full course of ACT, antibi-
otics, or ORS, respectively. The primary outcomes of the
model-based health and economic analysis are life-years
(LY) gained, DALYs averted and incremental costs of the
program.
Study setting
Malawi has 28 districts across three regions—North,
Central, and South (Figure 2). Administratively, the dis-
tricts are subdivided into traditional authorities (TAs).
Each TA is composed of villages, which are the smallestFigure 1 Quasi-experimental study design, with 3 separate cross-sect
samples at 12 and 24 months are conducted for the population-based househadministrative units. There are three levels of health care:
(1) the primary level, which operates at the village level,
consists of village clinics operating community-based Inte-
grated Management of Childhood Illness (cIMCI), health
posts, dispensaries, maternities, health centers, and com-
munity and rural hospitals; (2) the secondary level, which
operates at the district level, consists of district hospitals;
and (3) the tertiary level which consists of four specialist
referral central hospitals [11]. The PAs are deployed to
health centers, one of the seven different types of health fa-
cilities at the primary level.
Intervention
The intervention is the 2-year certificate program to
train and deploy a new cadre of PAs established in 2012.
A partnership between the Malawi College of Health
Sciences (MCHS), Malawi Ministry of Health (MoH),
and the VillageReach, with technical assistance provided
by the University of Washington, the program seeks to
train and deploy at least 150 PAs to improve pharma-
ceutical management in rural HCs in Malawi. The inter-
vention is being implemented in 18 districts selected
from the three regions of the country where a motivated
and knowledgeable pharmacy technician at the district
hospital indicated a willingness to provide mentorship
and technical support to PA trainees during their train-
ing at hospitals and at the HC.
During the first year of training, students undergo
10 weeks of class-based instruction at MCHS. At the
end of this time period, half the students are deployed to
district hospitals for a 5-month period of field training
supervised by a pharmacy technician, and the other half
of the students remain at the MCHS for additional di-
dactic training; the students then change places for an-
other 5 months. In the second year, half of the trainees
are deployed to HCs in the intervention districts for
5 months while the other half will remain at the MCHS
for class-based instruction; the students then changeional samples. One pre-intervention and two post-intervention
old survey and the health center-based time-motion and patient surveys.
Figure 2 Map of Malawi indicating study districts. Ntchisi and
Machinga marked in pink are the intervention sites and Chikwawa
and Dedza marked in yellow are the comparison sites.
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ond year, HCs in intervention districts have a trainee PA
on-site for 10 of 12 months. Members of the teaching
staff from MCHS conduct routine supervisory visits at
both district hospitals and HCs to provide on-site men-
torship and assess student progress.
At the HCs, PA trainees are responsible for health
commodity management including stock room manage-
ment, storage, stock cards and record keeping, placing
emergency orders and collecting commodities from thedistrict health office, and completing logistics manage-
ment information system (LMIS) reports guided by the
Malawi health commodities Logistics Management
System Standard Operating Procedures manual [22].
Additionally, they are responsible for dispensing and
providing counseling to patients and supervising and
managing commodities used by the community health
workers based out of their HC.
Study sites
Four districts were purposively selected for the impact
evaluation: Ntchisi and Machinga as the intervention
sites and Chikwawa and Dedza as the comparison sites
(Figure 2). These districts were matched on region; level
of malaria, pneumonia, and diarrheal risk; access to the
basic services (roads, water, education, health centers,
and markets); geographic distinctions such as mountain
vs. lake regions; and socioeconomic status of residents.
The time-motion and patient surveys were conducted
at four health centers, one from each district, as fol-
lows: Khuwi in Ntchisi district, Ntaja in Machinga
district, Dolo in Chikwawa district, and Lobi HC in
Dedza district. The household surveys were conducted
in villages surrounding the four HCs chosen for the
evaluation.
Study procedures and sampling
Baseline surveys were conducted in March 2014 prior to
PA deployment to HCs. Additional surveys are planned
at 12 and 24 months after PA trainee deployment to the
intervention sites. The post-intervention surveys are
timed to occur after a PA trainee has been consistently
available at the HC for at least 6 months. We assume
that over this period, the trainee will have had sufficient
time to settle into a working routine and will have had
an impact on routine functioning of the logistics system
and dispensing practices, and hence an impact on avail-
ability and use of medicines at the HC.
At each health center, time-motion and patient surveys
will be conducted on each day of the work week from
Monday to Friday for one full week. This is necessary to
capture the day-to-day distribution of patient load. The
survey samples consist of all consenting out-patients vis-
iting the HC on the day of the survey. This is important
to identify bottlenecks in service delivery. Research staff
will provide each patient with the time-motion question-
naire that they will move with throughout the clinic
visit. Health workers that interface with patients will fill
out time sheets noting the time as soon as a patient ap-
pears at their station and the time when they leave their
station. The health worker at the last health-care station
will send the patient back to research staff for the pa-
tient survey. The research staff will also record the start
and end times of the experiential survey.
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two-stage cluster sampling design. The study samples
consist of randomly selected households with children
between 2–59 months of age within census enumeration
areas (EAs) adjacent to the each HC. Inclusion criteria
are as follows: 1) household representative consent to
participate in the study, and 2) at least one child be-
tween 2–59 months with reported symptoms of non-
severe malaria, pneumonia, or diarrhea in the previous
2 weeks. For malaria, only those children for whom the
caretaker or household representative reports a history
of fever will be included. For children with non-severe
pneumonia, those with a history of cough or difficulty
breathing and a rapid respiratory rate will be included;
for diarrhea, those who report a history of loose watery
stools will be included [23]. These are children who
should have received either ACTs for non-severe mal-
aria, an antibiotic for non-severe pneumonia, or ORS for
diarrhea. We will exclude all those with severe malaria
or pneumonia and those under 2 months of age because
ACTs are contraindicated in this age group, and any
child under 2 months of age with cough or difficulty
breathing is considered to have severe pneumonia. We
will also exclude those children whose caregivers report
them as having bloody stools.
In the first stage, we will identify all EAs within a
district based on the data available from the Malawi
National Statistics Office. Clusters will be selected
based on their proximity to selected health centers in
both the intervention and comparison districts. We
will sample from the 30 closest EAs to each of the four
health centers. In the second stage, we shall identify
one or more central points in the village such as a
market or school, choose a direction or route at ran-
dom, count the number of households between that
point and the edge of the village, and then select one
of these as the starting point. Every subsequent tenth
household will then be selected systematically until the
targeted number of households for that cluster has
been screened. Emphasis will be placed on ensuring as
widespread coverage as possible in each EA and achieving
a random or near-random selection of households. Proce-
dures used in household sampling in each EA will be
reported in detail. Households will be approached for
screening according to the inclusion and exclusion cri-
teria. For households with eligible and consenting partici-
pants, the survey questionnaire will be administered for
each child who meets our inclusion criteria.
Sample size
According to the Malawi DHS, 2010, approximately
35%, 7%, and 18% of children between 2–59 months re-
ported having malaria, pneumonia symptoms, or a diar-
rhea episode, respectively, in the 2 weeks preceding thesurvey [21]. Of these children, 36%, 24%, and 69% re-
ceived an ACT for malaria, antibiotic for pneumonia,
and ORS for diarrhea, respectively [21]. Our aim is to
detect modest and meaningful increases in access to
ACTs, antibiotics, and ORS to 50%, 40%, and 80%, re-
spectively, with 80% power and 5% precision. We would
require a random sample of at least 390 children with
non-severe malaria, 264 children with pneumonia, and
490 with diarrhea at each cross-section, divided equally
between intervention and comparison groups to demon-
strate the proposed effect sizes [24]. However, this is a
population-based household cluster sample requiring
initial screening of households for children reporting
non-severe malaria, pneumonia, or diarrhea in the previ-
ous 2 weeks. Therefore, to achieve these sample sizes,
given an expected prevalence of a febrile episode, pneu-
monia symptoms and diarrhea episode of 35%, 7%, and
18%, respectively, and assuming there are 1.5 children
per household between 2–59 months old, a household
non-response rate of 10%, and a design effect of 1.5 to
account for within-cluster homogeneity in the primary
outcome [21,25], we estimated that we needed to screen
approximately 1,226 households for children with mal-
aria, approximately 4,149 households for children with
pneumonia, and 782 households for children with diar-
rhea. We chose the largest sample size, i.e., 4,150 house-
holds at each cross-section: 2,075 households in the
intervention and 2,075 in the comparison districts.
Study questionnaires
The HC-based time-motion and patient survey question-
naires were developed for this evaluation. The time-
motion survey consists of a time-sheet for recording
movements throughout the clinic, including the time of
presentation to the health center, waiting times, and
time-in and time-out for different services such as seeing
the triage nursing assistant, the medical assistant, and/or
the pharmacy worker. The patient survey consists of a
series of questions related to the patient’s experience at
the health center, any medicines prescribed by the clin-
ician, and dispensed at the pharmacy.
The household survey questionnaire was adapted from
the 2010 Malawi Demographic and Health Survey
Household and Women’s questionnaires [21]. It consists
of three sections: screening, household, and care-seeking
and medicine-use sections. The screening section identi-
fies potential participants who report having had symp-
toms suggestive of non-severe malaria, pneumonia, or
diarrhea in the previous 2 weeks. The household section
captures information on the demographic characteristics
of all usual members of the household including their
ages, gender, education, relationship to the household
head, and marital status (of those above age 18). It also
captures various socioeconomic indicators including
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water, electricity, and toilet facilities, type of fuel used to
cook, ownership of material items like radios, televisions
and cell phones, material of floors, roof and walls in the
house, ownership of land, livestock and poultry, and
ownership of a bank account. The care-seeking and
medicine-use section first captures data on whether care
was sought for the illness episode, and if care was
sought, where, after how long, distance travelled, time and
cost of seeking care. It also captures information on anti-
malarials, antibiotics, ORS, and other supportive treat-
ments received, and the time and costs spent looking after
the sick child.
The study questionnaires were translated to Chichewa,
the other official language of Malawi (in addition to English),
back-translated to ensure no loss of information, and
edited further where necessary. We conducted a 1-
week training of research assistants and supervisors at
which we discussed the study procedures and per-
formed an in-depth review of the questionnaires. The
questionnaires were pretested, and minor changes
made to both the questionnaires and study procedures.
Analytic strategy
Data from the questionnaires will be double-entered
and cross-validated in the Census and Survey Process-
ing System, CSPro (US Census Bureau, USA). Analyses
will be conducted using STATA version 12.1 (StataCorp
LP, College Station, TX, USA). The decision analytic
model for the economic evaluation will be analyzed in
Microsoft Excel 2010 (Microsoft Corp., Redmond, WA,
USA).
A socioeconomic status index will be constructed by
principal component analysis of data on ownership of
durable goods and housing characteristics collected in
the household module of the survey questionnaire [26].
In bivariate analyses, we will summarize the characteris-
tics of enrolled participants and households by interven-
tion and comparison district as proportions for categorical
variables and means (standard deviation) for continuous
variables. Pearson’s chi-square tests will be used to com-
pare proportions and t-tests to compare continuous vari-
ables between intervention and comparison groups.
In the primary analysis, we will use a difference-in-
differences estimator within a multivariable regression
framework [27,28], to estimate the causal effect of PA
training and deployment on access to the tracer commod-
ities, adjusting for potential confounders including 1) pri-
mary caregiver demographics—age, gender, education
level, employment status, and marital status; 2) patient
demographics—age and gender of the patient; 3) house-
hold characteristics—household income and expenditure,
socioeconomic index group; and 4) proxies for access to
care—distance (and time cost) to nearest health facility.Economic evaluation
We are developing a decision analytic model to repre-
sent the consequences of differential access to ACTs, an-
tibiotics, and ORS on morbidity, mortality, DALYs, and
costs due to malaria, pneumonia, and diarrhea, respect-
ively. The modeling framework will take the form of a
decision tree that tracks access to medicines. The mor-
bidity consequence of access/no access to treatment is
potential progression to severe disease or sequelae. The
model will track care-seeking patterns and treatment
patterns for severe disease or sequelae as well as survival.
The probabilities of accessing an ACT, an antibiotic, or
ORS will be derived from our quasi-experimental evalu-
ation. We are systematically synthesizing current evidence
from the literature to obtain all other model probabilities,
life expectancies, and disability weights.
The economic evaluation is being conducted both
from the perspective of the Malawi Government Minis-
try of Health and from a societal perspective. We shall
estimate the direct and indirect costs of routine health
service provision and program implementation in the
intervention facilities and routine health service provision
in the comparison facilities. These resource use and cost
data shall be derived from the program and health center
accounting systems. Using a time-motion study and patient
interviews, we shall estimate the direct medical and non-
medical costs and indirect costs (productivity losses) asso-
ciated with treating malaria, pneumonia, and diarrhea in
hospitals. All costs are being converted to 2014 US dollars
(US$). Costs and outcomes will be discounted at 3% [29].
Incremental cost-effectiveness ratios (ICERs) will be
calculated as the incremental cost per life-year saved
and incremental cost per DALY averted. Scenario ana-
lyses and univariate and probabilistic sensitivity analyses
will be performed to examine the impact of assumptions
and uncertainty around model parameters on life-years
gained, DALYs averted, and incremental costs.Ethical considerations
Ethical clearance was obtained from the University of
Washington Institutional Review Board and the Malawi
National Health Sciences Research Committee (NHSRC).
Informed consent is being sought from all participants
prior to administering the study instruments. The consent
forms and study instruments are available in Chichewa
and English.Study status
Baseline surveys, including the population-based house-
hold and HC-based time-motion and patient surveys,
were conducted in March 2014. Implementation of the
intervention began in April 2014. PA trainees have been
deployed at the study health centers for 5 months.
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This paper describes the protocol for a cluster quasi-
experimental design study whose aim is to determine
the impact of having trained pharmacy personnel in
rural health centers on access to medicines and clinical
care at health facilities. We are using decision analytic
methods to model the impact of the intervention on health
outcomes, specifically child morbidity and mortality and
costs. This decision model will also form the basis of an as-
sessment of the cost-effectiveness of the intervention.
Innovation and potential impact
The lack of trained pharmacy staff at the health center
service delivery level to manage medicines and supply
chain has become a critical bottleneck in national efforts
to improve access to medicines and primary health-care
service delivery. The demand for pharmaceutical ser-
vices, particularly with the advent of the HIV/AIDS epi-
demic, has increased markedly and points to the need
for a comprehensive and sustainable scale up of the
pharmaceutical workforce in low-income countries like
Malawi. This project seeks to evaluate the causal effect
of a potentially efficient, community-level intervention
in which pharmaceutical services at lower-level health
facilities are delegated to lower-level cadre pharmacy
worker. We theorize that addressing this human re-
sources constraint will improve medicines management,
logistics information flow, and supply chain function at
the health facility level, leading to improved medicines
availability at public health facilities, access to essential
medicines in the community and health outcomes. Al-
though similar programs are already being implemented
in Namibia, South Africa, and Tanzania, associated costs
and impact on medicines availability at public health fa-
cilities have not been reported. Moreover, the impact of
supply chain enhancements on health outcomes has also
not been rigorously evaluated.
Limitations
We limit our primary analysis to evaluating the impact
of the intervention on community level access to the
tracer medicines and the impact on service provision at
the health facilities. Decision analytic methods (informed
by the literature and our primary study) are used to ex-
trapolate to health outcomes. As such, we are unable to
directly quantify the direct impact of this program on
actual morbidity and mortality. It was not possible to
randomly assign the PAs to intervention and comparison
districts, due to political and geographic constraints. It is
therefore possible that there will be observed and unob-
served differences in the baseline measures of the inter-
vention and comparison groups that may account for
differences in outcomes. However, the use of difference-
in-differences analytic methods in a regression frameworkwill allow us to account for both observed and unobserved
confounders. There will likely remain questions of how
much of the improvement is on account of training and
deployment per se, and how much of it is due to better
motivation of the newly deployed PAs. This will be impos-
sible to tease out quantitatively.
As previously mentioned, differences in drug availabil-
ity, resulting from national supply shortages, may
present a challenge to the internal validity of the evalu-
ation. However, we do not expect this would be differen-
tial between intervention and control districts. To protect
against differential access resulting from differential avail-
ability of medicines at the district health offices, we se-
lected districts that had a track record of maintaining
adequate stocks of the tracer commodities throughout the
previous year. Our assumption is that national shortages
of medicines will affect facilities in both intervention and
control districts similarly.
It is worthwhile to note that the impact of the PA pro-
gram may extend beyond availability and consequently
community access to the tracer commodities. Access to
all products that are routinely used at the health centers
may improve and as a consequence morbidity and mor-
tality from the conditions that those commodities target,
e.g., vaccines and vaccine preventable diseases. Therefore,
any estimates we obtain may underestimate the potential
impact of the program on overall under-5 mortality.
Conclusions
This protocol describes the evaluation of an innovative
human resources intervention aimed at improving the
medicines supply chain in a low-income country, Malawi.
It will generate robust evidence on the effect of such inter-
ventions on community-level access to essential medicines
and the impact on clinic level operations. To further guide
national- and region-wide policy implementation, we will
model the impact of the intervention on costs, health out-
comes, and cost-effectiveness.
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